Grantham, Mayo, Van Otterloo & Co (GMO)
STN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Stantec STN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio STN Stock Details STN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,526
Closed -$621K – 578
2023
Q3 		$621K Buy
+9,526
New +$633K ﹤0.01% 479
2020
Q4 		– Sell
-32,500
Closed -$984K – 883
2020
Q3 		$984K Buy
32,500
+24,800
+322% +$786K 0.01% 516
2020
Q2 		$237K Buy
+7,700
New +$225K ﹤0.01% 693

Other funds holding STN

Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s STN Position: Q4 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Stantec (STN) in Q4 2023, closing a stake of 9,526 shares — an estimated $621K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in STN in Q2 2020 and held it in 3 quarters. The position peaked at $984K in Q3 2020. 220 funds tracked by Wall St. Rank hold STN as of Q4 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Stantec position as of Q4 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,526 Stantec shares in Q4 2023, an estimated $621K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stantec in Q2 2020 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Stantec position peaked at $984K in Q3 2020.
  • 220 funds tracked by Wall St. Rank held Stantec as of Q4 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.